[
  {
    "ts": null,
    "headline": "​Sanofi (SNY) Strengthens Shareholder Returns Amid Robust 2025 Performance and Long-Term Growth Outlook",
    "summary": "Sanofi (NASDAQ:SNY) is one of the best 52-week low blue-chip stocks to buy right now. On January 29, Sanofi SA (NASDAQ:SNY) reiterated plans to conduct a €1 billion share buyback in 2026. The buyback push comes as the company delivered a strong Q4 2025. Sanofi posted strong fourth-quarter results, driven by surging demand for its […]",
    "url": "https://finnhub.io/api/news?id=f309f15396f66fa56258282ec2ca68d594468378ab0e8471372f8bfa686c2b43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770542840,
      "headline": "​Sanofi (SNY) Strengthens Shareholder Returns Amid Robust 2025 Performance and Long-Term Growth Outlook",
      "id": 138391700,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Sanofi (NASDAQ:SNY) is one of the best 52-week low blue-chip stocks to buy right now. On January 29, Sanofi SA (NASDAQ:SNY) reiterated plans to conduct a €1 billion share buyback in 2026. The buyback push comes as the company delivered a strong Q4 2025. Sanofi posted strong fourth-quarter results, driven by surging demand for its […]",
      "url": "https://finnhub.io/api/news?id=f309f15396f66fa56258282ec2ca68d594468378ab0e8471372f8bfa686c2b43"
    }
  }
]